Texas

Texas is a state of stark contrasts — sprawling cities, rural communities, and a booming clean-energy sector all sharing the same landscape. This archive tracks progress stories from across the Lone Star State, from environmental wins and public health gains to community-led initiatives and policy advances.

A scientist examines a sample in a research laboratory for an article about Texas ibogaine research funding

Texas launches largest state psychedelic research program in U.S. history

Texas ibogaine research just got a 0 million boost, marking the largest state-funded psychedelic research initiative in U.S. history. The Texas Legislature passed HB 3717 with bipartisan support, authorizing supervised clinical trials of ibogaine — a plant-derived compound long blocked by federal Schedule I classification — with a potential 00 million total investment when matched by a participating drug developer. The program prioritizes military veterans and first responders suffering from treatment-resistant PTSD and opioid addiction, populations with few effective options under current medicine. A landmark Stanford study found a single ibogaine dose reduced veteran disability ratings by 88 percent on average, making this funding a significant step toward mainstream clinical validation.

A person repairing a smartphone circuit board for an article about right to repair laws

Right to repair laws have now been introduced in all 50 U.S. states

Right to repair legislation has now been introduced in all 50 U.S. states, marking a historic milestone for the consumer rights movement. In 2025, five states — New York, California, Minnesota, Oregon, and Colorado — passed laws requiring manufacturers to provide independent shops and individual owners with the parts, tools, and documentation needed to fix their own devices and equipment. This matters because it breaks the manufacturer-controlled repair monopoly that has driven up costs, reduced competition, and accelerated electronic waste. The milestone reflects eleven years of broad, bipartisan grassroots organizing — and with active bills in 24 states, momentum is only growing.

Molly Cook, for article on LGBTQ+ Texas Senate

Molly Cook just became the first out LGBTQ+ person elected to the Texas Senate

Molly Cook just became the first openly LGBTQ+ person ever elected to the Texas Senate, winning her Houston-area special election with 57% of the vote. An emergency room nurse and sixth-generation Texan, she built her campaign around a simple idea: the laws passed in Austin show up in her ER, whether it’s a miscarriage complication under the state’s abortion ban or a neighbor freezing after the power grid fails. Her win places an out senator in a chamber that has produced some of the country’s harshest anti-LGBTQ+ legislation. Representation in rooms like this one doesn’t change everything overnight, but it changes who has to be seen, and that’s how long-standing ceilings start to crack.

Depiction of nerve cells, for article on non-opioid compound

Researchers discover an effective non-opioid treatment for nerve pain

Nerve pain affects an estimated one in ten adults in the U.S., and for many, nothing currently available offers real relief. A new compound called FEM-1689 reduced pain hypersensitivity in mice with diabetic and chemotherapy-induced neuropathy, working through a receptor entirely separate from opioid pathways and sidestepping addiction risk. The same cellular effect was observed in human neurons in the lab. All results remain pre-clinical, and many promising compounds fail before reaching patients. But the mechanistic clarity here puts a genuinely safer treatment for one of medicine’s most stubborn problems on much firmer ground.

Neurons inside human brain, for article on fentanyl relapse brain circuit

Brain circuit breakthrough paves way for opioid addiction treatments

Scientists have discovered a specific brain circuit that drives the emotional crash—anxiety, depression, craving—keeping people trapped in the fentanyl cycle even after they’ve stopped using. By identifying this discrete target, researchers now have a concrete mechanism to aim at rather than the broad-brush approach of current treatments. The finding matters because it fills a gap addiction medicine has long faced: understanding exactly how fentanyl rewires the brain. This precision opens a path toward tailored therapies that could ease withdrawal’s emotional weight and improve the odds of lasting recovery.\n\n**Word count: 99**